Company Overview and News

1
Hands-on Toyota exec passes down monozukuri spirit

2018-04-15 japantimes.co.jp
TOYOTA, AICHI PREF. – Mitsuru Kawai drops by a bathhouse for factory workers at Toyota Motor’s headquarters in Aichi Prefecture each day before work.
Upvote Downvote

 
U.S. Steel (X) Up 39% in 6 Months: What's Driving the Stock?

2018-03-27 zacks
Shares of United States Steel Corporation (X - Free Report) have rallied 39.2% in the last six months, significantly outperforming the industry’s gain of roughly 12.6%.
Upvote Downvote

 
Kobe Steel’s new CEO vows to restore damaged trust with program of reforms

2018-03-16 japantimes.co.jp
The newly appointed president and chief executive officer of Kobe Steel Ltd. vowed Friday to restore damaged trust caused by a data-falsification scandal at the firm, saying it is essential to rebuild corporate governance and culture.
Upvote Downvote

 
New head of scandal-hit Kobe Steel may seek mergers for some business units

2018-03-16 reuters
(Reuters) - Kobe Steel’s new president on Friday said he may seek mergers or alliances outside the company for one or more of its business divisions, as he battles to repair damage from a data fraud scandal that roiled Japanese industry.
Upvote Downvote

1
Kobe Steel and Toyota sued over the steel-makers’ fabricated data

2018-03-14 japantimes.co.jp
Kobe Steel Ltd. said Wednesday that two U.S. consumers have filed a class-action lawsuit against the steel-maker and Toyota Motor Corp., seeking compensation for substandard metals used in vehicles.
Upvote Downvote

 
Japan's Aso: whether to attend G20 depends on situation in parliament

2018-03-13 channelnewsasia
Japan's finance minister is considering skipping a Group of 20 finance leaders' gathering in Buenos Aires next week, Kyodo news agency reported, as a suspected cover-up of a cronyism scandal paralyses parliament and puts his job on the line.
Upvote Downvote

 
Yamaguchi named Kobe Steel’s new CEO in wake of fake data scandal

2018-03-09 japantimes.co.jp
Steel-maker Kobe Steel on Friday named a new CEO and pledged “fundamental reforms” in the wake of a scandal over fake strength and quality data it submitted to clients.
Upvote Downvote

1
Japan's Kobe Steel names Yamaguchi as president after data fraud

2018-03-09 channelnewsasia
Japan's Kobe Steel Ltd on Friday appointed the head of its machinery business as its new president and chief executive, looking outside its major steel division for leadership in the wake of a widespread data fraud scandal.
Upvote Downvote

 
Japan's Kobe Steel names Yamaguchi as president after data fraud

2018-03-09 reuters
TOKYO (Reuters) - Japan’s Kobe Steel Ltd (5406.T) on Friday appointed the head of its machinery business as its new president and chief executive, looking outside its major steel division for leadership in the wake of a widespread data fraud scandal.
Upvote Downvote

1
Kobe Steel Joins Ranks of Japan Bonds Reviving After Scandal - Bloomberg

2018-03-09 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Stocks in Japan, South Korea surge on news of Trump-Kim meeting - MarketWatch

2018-03-09 marketwatch
Japanese and South Korean stocks rose sharply Friday morning, leading gains across Asia-Pacific, on news that North Korean leader Kim Jong Un and President Donald Trump agreed to meet by May.
Upvote Downvote

 
Stocks in Asia gain after news of potential US tariff exemptions

2018-03-08 moneycontrol
Markets in Asia clawed back some gains on Thursday after sliding in the last session on trade-related fears. Gains in the region came after US stocks closed above session lows on fresh developments related to planned metals tariffs.
Upvote Downvote

 
Asia markets: US metals tariffs, currencies and oil in focus

2018-03-08 cnbc
Markets in Asia clawed back some gains on Thursday after sliding in the last session on trade-related fears. Gains in the region came after U.S. stocks closed above session lows on fresh developments related to planned metals tariffs.
Upvote Downvote

 
Flash - Asian markets swing as Trump trade worries offset N.Korea hopes - France 24

2018-03-07 france24
Asian markets and the dollar were jolted Wednesday as news that Donald Trump's top economics advisor had resigned revived trade war fears, though the losses were tempered by North Korea's offer of denuclearisation talks.
Upvote Downvote

 
Asian markets swing as Trump trade worries offset North Korea hopes - Channel NewsAsia

2018-03-07 channelnewsasia
HONG KONG: Asian markets and the dollar were jolted on Wednesday (Mar 6) as news that Donald Trump's top economics adviser had resigned revived trade war fears, while early excitement at North Korea's offer of denuclearisation talks fizzled out.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: J34555144